7.45
price down icon8.02%   -0.65
after-market Handel nachbörslich: 7.82 0.37 +4.97%
loading

Finanzdaten der Passage Bio Inc-Aktie (PASG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Research and Development
25.80%
5.418
4.307 5.814 7.737 -
Operating Income/Loss
60.00%
-13.85
-8.655 -10.33 -16.46 -14.27
Income/Loss From Continuing Operations Before Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Income/Loss From Continuing Operations After Tax
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Net Income/Loss
67.54%
-12.98
-7.749 -9.385 -15.40 -12.72
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Diluted Average Shares
99.93%
0.0023
3.1787 3.1689 62.11 0.4845
Basic Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Diluted Earnings Per Share
67.62%
-4.09
-2.44 -2.96 -0.25 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):